Archives

Planning for a Talented Workforce: Building a Staffing Plan for New or Expanding GMP Facilities
Blog Post

Planning for a Talented Workforce: Building a Staffing Plan for New or Expanding GMP Facilities

Let’s contrast two very real scenarios: You are responsible for bringing a new GMP facility or line to full-scale production. Your board or shareholders expect...

Read More
Blog Post

Chromatography in Biologics Manufacturing: Purification Science, Resin Applications, and System Qualification

Chromatography in Biologics Manufacturing: Science, Purpose, and Resin Applications  Chromatography is a critical purification technique used in many evolving fields of biologics manufacturing including monoclonal...

Read More
Blog Post

From Day One Success to Everyday Improvement: The OR → OE Continuum 

Written by Paige Kane, PhD, CPIP   If you work in Life Sciences, you know that it is a complex, high-stakes operation.  I’ve been through my...

Read More
Blog Post

Human Performance In Pharma: Strengthening The Biotech Workforce

Elevating human performance in pharma starts with addressing the workforce shortage and continues by transforming how organizations develop and support their people. Through strategic collaboration...

Read More
Blog Post

Reimagining Pharmaceutical Manufacturing: Why the latest E2500-25 Standard Revision Demands Immediate Action 

Speed to patient is a primary driver behind the industry's shift toward modern commissioning and qualification (C&Q) practices, while still ensuring product quality and patient...

Read More
Blog Post

EU GMP Annex 1 Compliance: Global Requirements & PIC/S Alignment

The 2023 revision of EU GMP Annex 1 reset the global standard for sterile manufacturing. It expands the guidance, tightens contamination-control expectations and aligns requirements...

Read More
Blog Post

WINDSOR FRAMEWORK: WHAT IS IT?

The Windsor Framework (WF), which came into effect on January 1, 2025, is a significant agreement between the UK and the EU that replaces the...

Read More
Blog Post

CAI Appoints Jamie Robertson as Vice President of Mission Critical to Drive Innovation and Operational Excellence Across Global Infrastructure Projects 

August 11, 2025 – Indianapolis, IN — CAI, a global leader in operational readiness and excellence for high-stakes, regulated environments, is proud to announce the...

Read More
Blog Post

Understanding cGMPs for Phase 1 Investigational Drugs

In 2008, the FDA issued guidance exempting most Phase 1 investigational drugs from the full scope of Title 21 of the Code of Federal Regulations...

Read More
Blog Post

CAI and Valkit.ai Form Strategic Partnership to Advance Gen2 AI-Augmented Validation (DVT) in Life Sciences 

CAI and Valkit.ai Form Strategic Partnership to Advance Gen2 AI-Augmented Validation (DVT) in Life Sciences  Indianapolis, IN – September 29, 2025 — CAI, a global...

Read More